Parkinson's Disease Tulip


advertisement
Reply
 
Thread Tools Display Modes
Old 09-16-2009, 08:05 PM #1
Stitcher's Avatar
Stitcher Stitcher is offline
Magnate
 
Join Date: Aug 2006
Posts: 2,136
15 yr Member
Stitcher Stitcher is offline
Magnate
Stitcher's Avatar
 
Join Date: Aug 2006
Posts: 2,136
15 yr Member
Thumbs up MJFF Commits Up to $12 Million for Targeted PD Therapeutic Development in 2010

Michael J. Fox Foundation Commits Up to $12 Million for Targeted Parkinson's Therapeutic Development in 2010

Tue Sep 15, 2009 2:30pm EDT
http://www.reuters.com/article/press...09+PRN20090915

NEW YORK, Sept. 15 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation has committed up to $12 million in 2010 funding for prioritized research toward transformative treatments and a cure for Parkinson's disease.

Funding is open to academic and industry researchers through the Foundation's Pipeline Programs, which consist of three annually recurring initiatives, known collectively as The Edmond J. Safra Core Programs for PD Research, as well as the industry-exclusive Therapeutics Development Initiative. The Foundation seeks investigator-initiated proposals focused on the following critical points along the translational pathway to new therapies for Parkinson's disease:
  • Testing Novel Hypotheses: Quick support for high-risk, high-reward projects with little to no existing preliminary data, but potential to significantly impact our understanding or treatment of PD.
  • Validating Novel Targets: Support for work demonstrating whether modulation of a novel biological target has impact in a PD-relevant pre-clinical model -- an essential step to the development of potential targeted therapies.
  • Catalyzing and Expanding Preclinical Development: Industry-exclusive support for preclinical development of Parkinson's disease therapies with potential to fundamentally alter disease course and/or improve treatment of symptoms above and beyond current standards of care.
  • Clinically Testing Novel Therapies: Support for clinical testing of promising PD therapies that may significantly and fundamentally Improve treatment of PD.
__________________
You're alive. Do something. The directive in life, the moral imperative was so uncomplicated. It could be expressed in single words, not complete sentences. It sounded like this: Look. Listen. Choose. Act. ~~Barbara Hall

I long to accomplish a great and noble tasks, but it is my chief duty to accomplish humble tasks as though they were great and noble. The world is moved along, not only by the mighty shoves of its heroes, but also by the aggregate of the tiny pushes of each honest worker. ~~Helen Keller
Stitcher is offline   Reply With QuoteReply With Quote

advertisement
Old 09-19-2009, 07:27 PM #2
pegleg's Avatar
pegleg pegleg is offline
Senior Member
 
Join Date: Sep 2006
Location: Tennessee
Posts: 1,213
15 yr Member
pegleg pegleg is offline
Senior Member
pegleg's Avatar
 
Join Date: Sep 2006
Location: Tennessee
Posts: 1,213
15 yr Member
Default Wow!

I believe at last count, the Fox Foundation had put about $149 million into Parkinson's research! And they really haven't been in existence all that long.

Thank you, Thank you MJF!!!

Peg
pegleg is offline   Reply With QuoteReply With Quote
Old 09-20-2009, 05:19 PM #3
ashleyk ashleyk is offline
Member
 
Join Date: Oct 2006
Location: New England
Posts: 262
15 yr Member
ashleyk ashleyk is offline
Member
 
Join Date: Oct 2006
Location: New England
Posts: 262
15 yr Member
Default LDN? Dr. Hong @ NIH???

Somehow I'm not very excited by the MJFF. I hope they do make some important contributions in the fight against PD but I wonder. I've tried in the past to bring their attention to low dose naltrexone, LDN, which many people take for MS but not very many with PD. One can go to the yahoo lowdosenaltrexone web site to see the thousands of anecdotal comments made for LDN but I prefer to believe in the research done at the NIH by Dr. Hongs Pharmacology group. They have produced many papers over the past 10 years on low doses of naltrexone, dextromethorphan and other similar compounds which have shown to greatly reduce over activated microglia (killer cells) in the brains of rodents. Over activated microglia are believed to be the latest cause of PD.
I have been taking LDN and Sinemet now for 5 years and 3 months. I still take a small amount of Sinemet and also a small amount of Mirapex. The overall mix has not been increased over this time. I now have ankle swelling and after reading the post here on Mirapex like drugs causing heart valve scarring, I now have something else to worry about. I have cut back recently on Mirapex on my own. I have a neuro apt. in 3 weeks, I wonder if she will own up to the potential disaster awaiting many of us.
So if anyone can get MJF to talk to Dr. Hong, I would be more positive about his foundation.
Ashley
http://www.fasebj.org/cgi/content/full/19/6/550
http://jpet.aspetjournals.org/cgi/content/full/304/1/1
http://jpet.aspetjournals.org/cgi/co...urnalcode=jpet
ashleyk is offline   Reply With QuoteReply With Quote
Old 09-20-2009, 10:22 PM #4
wendy s wendy s is offline
Member
 
Join Date: Sep 2006
Posts: 199
15 yr Member
wendy s wendy s is offline
Member
 
Join Date: Sep 2006
Posts: 199
15 yr Member
Default

ashley, I've known for some time that pergolide (permax) was implicated in heart valve damage. I looked up more information, and it's the ergot-derived dopamine agonists (permax and cabergoline) that cause the valve damage. Mirapex is a non-ergot agonist, so it's okay for your heart (so far, anyway!).
wendy s is offline   Reply With QuoteReply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
MJFF funds million dollars for GDNF delivery paula_w Parkinson's Disease 2 08-15-2008 10:46 PM
MJFox Foundation Awards $2.4 Million For Validation Of Nine Therapeutic Targets Stitcher Parkinson's Disease 1 07-22-2008 09:13 AM
Targeted Genetics Corporation Recommended for up to $2.4 Million in Funding by Depart BobbyB ALS News & Research 0 07-10-2008 07:50 AM
MJFF: Commits up to $2 million to Visualize Alpha-Synuclein Protein in the Brain Stitcher Parkinson's Disease 0 06-03-2008 07:52 PM
MJFFoundation Commits Up to $2 Million to Improve Drug Delivery for PD Stitcher Parkinson's Disease 0 03-26-2008 11:19 PM


All times are GMT -5. The time now is 12:39 PM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.